{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:36:12Z","timestamp":1790714172281,"version":"4.1.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"DOI":"10.1038\/s41531-026-01344-5","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T10:35:05Z","timestamp":1777113305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Plasma proteomics for Parkinson\u2019s disease classification: cross-cohort benchmarking of proteomic, transcriptomic, and multimodal models"],"prefix":"10.1038","volume":"12","author":[{"given":"Nicholas","family":"Minster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleet","family":"Jafri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"1344_CR1","doi-asserted-by":"crossref","unstructured":"Dorsey, E. R., Sherer, T., Okun, M. S. & Bloem, B. R. The emerging evidence of the Parkinson pandemic. J. Parkinson\u2019s Dis. 8, S3\u2013S8 (2018).","DOI":"10.3233\/JPD-181474"},{"key":"1344_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neubiorev.2016.07.010","volume":"68","author":"AA Moustafa","year":"2016","unstructured":"Moustafa, A. A. et al. Motor symptoms in Parkinson\u2019s disease: a unified framework. Neurosci. Biobehav. Rev. 68, 727\u2013740 (2016).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"1344_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.mcna.2018.10.014","volume":"103","author":"SG Reich","year":"2019","unstructured":"Reich, S. G. & Savitt, J. M. Parkinson\u2019s disease. Med. Clin. North Am. 103, 337 (2019).","journal-title":"Med. Clin. North Am."},{"key":"1344_CR4","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S1474-4422(15)00178-7","volume":"14","author":"MA Nalls","year":"2015","unstructured":"Nalls, M. A. et al. Diagnosis of Parkinson\u2019s disease on the basis of clinical and genetic classification: a population-based modelling study. Lancet Neurol. 14, 1002\u20131009 (2015).","journal-title":"Lancet Neurol."},{"key":"1344_CR5","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1212\/WNL.0000000000002350","volume":"86","author":"G Rizzo","year":"2016","unstructured":"Rizzo, G. et al. Accuracy of clinical diagnosis of Parkinson disease: a systematic review and meta-analysis. Neurology 86, 566\u2013576 (2016).","journal-title":"Neurology"},{"key":"1344_CR6","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/ene.13919","volume":"26","author":"R Durcan","year":"2019","unstructured":"Durcan, R. et al. Prevalence and duration of non-motor symptoms in prodromal Parkinson\u2019s disease. Eur. J. Neurol. 26, 979\u2013985 (2019).","journal-title":"Eur. J. Neurol."},{"key":"1344_CR7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/WCO.0000000000000584","volume":"31","author":"V Rispoli","year":"2018","unstructured":"Rispoli, V., Schreglmann, S. R. & Bhatia, K. P. Neuroimaging advances in Parkinson\u2019s disease. Curr. Opin. Neurol. 31, 415\u2013424 (2018).","journal-title":"Curr. Opin. Neurol."},{"key":"1344_CR8","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/s41596-022-00787-3","volume":"18","author":"L Concha-Marambio","year":"2023","unstructured":"Concha-Marambio, L., Pritzkow, S., Shahnawaz, M., Farris, C. M. & Soto, C. Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid. Nat. Protoc. 18, 1179\u20131196 (2023).","journal-title":"Nat. Protoc."},{"key":"1344_CR9","doi-asserted-by":"publisher","first-page":"10932","DOI":"10.3390\/ijms241310932","volume":"24","author":"C Cocco","year":"2023","unstructured":"Cocco, C., Manai, A. L., Manca, E. & Noli, B. Brain-biomarker changes in body fluids of patients with Parkinson\u2019s disease. Int J. Mol. Sci. 24, 10932 (2023).","journal-title":"Int J. Mol. Sci."},{"key":"1344_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-023-09417-y","volume":"24","author":"C Gabbert","year":"2023","unstructured":"Gabbert, C. et al. GBA1 in Parkinson\u2019s disease: variant detection and pathogenicity scoring matters. BMC Genom. 24, 322 (2023).","journal-title":"BMC Genom."},{"key":"1344_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1080\/14728222.2020.1733970","volume":"24","author":"Y Chen","year":"2020","unstructured":"Chen, Y. et al. Glucocerebrosidaseas a therapeutic target for Parkinson\u2019s disease. Expert Opin. Ther. Targets 24, 287 (2020).","journal-title":"Expert Opin. Ther. Targets"},{"key":"1344_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-022-00354-3","volume":"8","author":"M Kedariti","year":"2022","unstructured":"Kedariti, M. et al. LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson\u2019s disease. NPJ Parkinsons Dis. 8, 1\u201314 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"1344_CR13","doi-asserted-by":"publisher","unstructured":"Smith, L. J., Lee, C. Y., Menozzi, E. & Schapira, A. H. V. Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease. Front. Neurol. 13, https:\/\/doi.org\/10.3389\/fneur.2022.971252 (2022).","DOI":"10.3389\/fneur.2022.971252"},{"key":"1344_CR14","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3390\/jpm11030169","volume":"11","author":"X Reed","year":"2021","unstructured":"Reed, X., Schumacher-Schuh, A., Hu, J. & Bandres-Ciga, S. Advancing personalized medicine in common forms of Parkinson\u2019s disease through genetics: current therapeutics and the future of individualized management. J. Pers. Med. 11, 169 (2021).","journal-title":"J. Pers. Med."},{"key":"1344_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1056\/NEJMoa1809983","volume":"380","author":"CVM Verschuur","year":"2019","unstructured":"Verschuur, C. V. M. et al. Randomized delayed-start trial of levodopa in Parkinson\u2019s Disease. N. Engl. J. Med. 380, 315\u2013324 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1344_CR16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.2174\/1871527319666200722153156","volume":"19","author":"H Bogetofte","year":"2020","unstructured":"Bogetofte, H., Alamyar, A., Blaabjerg, M. & Meyer, M. Levodopa therapy for Parkinson\u2019s disease: history, current status and perspectives. CNS Neurol. Disord. Drug Targets- CNS Neurol. Disord. 19, 572\u2013583 (2020).","journal-title":"CNS Neurol. Disord. Drug Targets- CNS Neurol. Disord."},{"key":"1344_CR17","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3233\/JPD-171181","volume":"8","author":"K Rosqvist","year":"2018","unstructured":"Rosqvist, K. et al. Levodopa effect and motor function in late stage Parkinson\u2019s disease. J. Parkinson\u2019s. Dis. 8, 59\u201370 (2018).","journal-title":"J. Parkinson\u2019s. Dis."},{"key":"1344_CR18","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/mds.27360","volume":"33","author":"AE Lang","year":"2018","unstructured":"Lang, A. E. & Espay, A. J. Disease modification in Parkinson\u2019s disease: current approaches, challenges, and future considerations. Mov. Disord. 33, 660\u2013677 (2018).","journal-title":"Mov. Disord."},{"key":"1344_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-021-00254-1","volume":"10","author":"M Xu","year":"2021","unstructured":"Xu, M., Zhu, J., Liu, X. D., Luo, M. Y. & Xu, N. J. Roles of physical exercise in neurodegeneration: reversal of epigenetic clock. Transl. Neurodegener. 10, 30 (2021).","journal-title":"Transl. Neurodegener."},{"key":"1344_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1586\/17512433.2014.905201","volume":"7","author":"NT Issa","year":"2014","unstructured":"Issa, N. T., Byers, S. W. & Dakshanamurthy, S. Big data: the next frontier for innovation in therapeutics and healthcare. Expert Rev. Clin. Pharmacol. 7, 293\u2013298 (2014).","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"1344_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00216-021-03813-7","volume":"414","author":"C Li","year":"2022","unstructured":"Li, C., Gao, Z., Su, B., Xu, G. & Lin, X. Data analysis methods for defining biomarkers from omics data. Anal. Bioanal. Chem. 414, 235\u2013250 (2022).","journal-title":"Anal. Bioanal. Chem."},{"key":"1344_CR22","doi-asserted-by":"publisher","unstructured":"Amelia, A., Pena-Castillo, L. & Usefi, H. Assessing the reproducibility of machine learning-based biomarker discovery in Parkinson\u2019s disease. Comput. Biol. Med. https:\/\/doi.org\/10.48550\/arXiv.2304.03239.2304.03239 (2023).","DOI":"10.48550\/arXiv.2304.03239.2304.03239"},{"key":"1344_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12264-019-00433-1","volume":"36","author":"T Li","year":"2020","unstructured":"Li, T. & Le, W. Biomarkers for Parkinson\u2019s disease: how good are they? Neurosci. Bull. 36, 183\u2013194 (2020).","journal-title":"Neurosci. Bull."},{"key":"1344_CR24","doi-asserted-by":"publisher","unstructured":"Makarious, M. B. et al. Multi-modality machine learning predicting Parkinson\u2019s disease. npj Parkinson\u2019s Dis. 8, https:\/\/doi.org\/10.1038\/s41531-022-00288-w (2022).","DOI":"10.1038\/s41531-022-00288-w"},{"key":"1344_CR25","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520957197","volume":"48","author":"J Shen","year":"2020","unstructured":"Shen, J. et al. Identification of Parkinson\u2019s disease-related pathways and potential risk factors. J. Int. Med. Res. 48, 0300060520957197 (2020).","journal-title":"J. Int. Med. Res."},{"key":"1344_CR26","doi-asserted-by":"publisher","first-page":"3742","DOI":"10.3390\/ijms23073742","volume":"23","author":"T Bakshi","year":"2022","unstructured":"Bakshi, T., Pham, D., Kaur, R. & Sun, B. Hidden relationships between N-glycosylation and disulfide bonds in individual proteins. Int. J. Mol. Sci. 23, 3742 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1344_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.662474","volume":"13","author":"GY Ou","year":"2021","unstructured":"Ou, G. Y., Lin, W. W. & Zhao, W. J. Neuregulins in neurodegenerative diseases. Front. Aging Neurosci. 13, 662474 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"1344_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s00401-020-02181-3","volume":"140","author":"S Bandres-Ciga","year":"2020","unstructured":"Bandres-Ciga, S. et al. Large-scale pathway specific polygenic risk and transcriptomic community network analysis identifies novel functional pathways in Parkinson disease. Acta Neuropathol. 140, 341\u2013358 (2020).","journal-title":"Acta Neuropathol."},{"key":"1344_CR29","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.87501","volume":"12","author":"CT Hong","year":"2024","unstructured":"Hong, C. T., Chung, C. C., Yu, R. C. & Chan, L. Plasma extracellular vesicle synaptic proteins as biomarkers of clinical progression in patients with Parkinson\u2019s disease. Elife 12, RP87501 (2024).","journal-title":"Elife"},{"key":"1344_CR30","doi-asserted-by":"publisher","first-page":"7435","DOI":"10.3390\/ijms24087435","volume":"24","author":"WA Rike","year":"2023","unstructured":"Rike, W. A. & Stern, S. Proteins and transcriptional dysregulation of the brain extra-cellular matrix in Parkinson\u2019s disease: a systematic review. Int. J. Mol. Sci. 24, 7435 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1344_CR31","doi-asserted-by":"publisher","unstructured":"Tonges, L. Blood-based biomarker in Parkinson\u2019s disease. Front. Aging Neurosci. https:\/\/doi.org\/10.1016\/S1353-8020(13)70025-7 (2022).","DOI":"10.1016\/S1353-8020(13)70025-7"},{"key":"1344_CR32","doi-asserted-by":"publisher","unstructured":"Yamashita, K. Biomarkers in Parkinson\u2019s disease: a state of the art review. Clin. Res. Hepatol. Gastroenterol. https:\/\/doi.org\/10.1016\/j.bionps.2023.100074 (2023).","DOI":"10.1016\/j.bionps.2023.100074"},{"key":"1344_CR33","doi-asserted-by":"publisher","unstructured":"Zarkali, A. Neuroimaging and fluid biomarkers in Parkinson\u2019s disease. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-024-49949-9 (2024).","DOI":"10.1038\/s41467-024-49949-9"},{"key":"1344_CR34","doi-asserted-by":"publisher","unstructured":"Hallqvist, J. Plasma proteomics identify biomarkers predicting Parkinson\u2019s disease up to 7 years before symptom onset. Brain; https:\/\/doi.org\/10.1038\/s41467-024-48961-3 (2024).","DOI":"10.1038\/s41467-024-48961-3"},{"key":"1344_CR35","doi-asserted-by":"publisher","unstructured":"Pereira, J. DOPA decarboxylase is an emerging biomarker for Lewy body disorders. Nat. Aging https:\/\/doi.org\/10.1038\/s43587-023-00478-y (2023).","DOI":"10.1038\/s43587-023-00478-y"},{"key":"1344_CR36","doi-asserted-by":"publisher","unstructured":"Rutledge, J. Comprehensive proteomics of CSF, plasma, and urine nominate biomarkers for early Parkinson\u2019s disease. Sci. Transl. Med. https:\/\/doi.org\/10.1007\/s00401-024-02706-0. (2024).","DOI":"10.1007\/s00401-024-02706-0"},{"key":"1344_CR37","doi-asserted-by":"publisher","unstructured":"Chang, K. Assessing plasma levels of \u03b1-synuclein and neurofilament light chain in Parkinson\u2019s disease. Front. Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2021.759182 (2021).","DOI":"10.3389\/fnagi.2021.759182"},{"key":"1344_CR38","doi-asserted-by":"publisher","unstructured":"Teodoro, T. Association between serum prolactin levels and neurodegenerative diseases: a meta-analysis. Neuroimmunomodulation. https:\/\/doi.org\/10.1159\/000519552 (2022).","DOI":"10.1159\/000519552"},{"key":"1344_CR39","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3390\/cells8060619","volume":"8","author":"S Rittchen","year":"2019","unstructured":"Rittchen, S. & Heinemann, A. Therapeutic potential of hematopoietic prostaglandin D2 synthase in allergic inflammation. Cells 8, 619 (2019).","journal-title":"Cells"},{"key":"1344_CR40","doi-asserted-by":"publisher","first-page":"11406","DOI":"10.3390\/ijms252111406","volume":"25","author":"SG Kim","year":"2024","unstructured":"Kim, S. G. et al. Integrative metabolome and proteome analysis of cerebrospinal fluid in Parkinson\u2019s disease. Int. J. Mol. Sci. 25, 11406 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1344_CR41","doi-asserted-by":"publisher","unstructured":"Winchester, L. et al. Identification of a possible proteomic biomarker in Parkinson\u2019s disease: discovery and replication in blood, brain and cerebrospinal fluid. Brain Commun. 5, https:\/\/doi.org\/10.1093\/braincomms\/fcac343 (2022).","DOI":"10.1093\/braincomms\/fcac343"},{"key":"1344_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23774-w","volume":"12","author":"T Wang","year":"2021","unstructured":"Wang, T. et al. MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification. Nat. Commun. 12, 3445 (2021).","journal-title":"Nat. Commun."},{"key":"1344_CR43","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbad378","volume":"24","author":"Y Lu","year":"2023","unstructured":"Lu, Y. et al. Multiomics dynamic learning enables personalized diagnosis and prognosis for pancancer and cancer subtypes. Brief. Bioinforma. 24, bbad378 (2023).","journal-title":"Brief. Bioinforma."},{"key":"1344_CR44","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbae185","volume":"25","author":"W Lan","year":"2024","unstructured":"Lan, W. et al. DeepKEGG: a multi-omics data integration framework with biological insights for cancer recurrence prediction and biomarker discovery. Brief. Bioinform. 25, bbae185 (2024).","journal-title":"Brief. Bioinform."},{"key":"1344_CR45","doi-asserted-by":"publisher","unstructured":"Ni, J. et al. PTMFusionNet: a deep learning approach for predicting disease related post-translational modification and classifying disease subtypes. Mol. Cell. Proteom. 24, https:\/\/doi.org\/10.1016\/j.mcpro.2025.101009 (2025).","DOI":"10.1016\/j.mcpro.2025.101009"},{"key":"1344_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbaf131","volume":"26","author":"J Ni","year":"2025","unstructured":"Ni, J. et al. MethPriorGCN: a deep learning tool for inferring DNA methylation prior knowledge and guiding personalized medicine. Brief. Bioinform. 26, bbaf131 (2025).","journal-title":"Brief. Bioinform."},{"key":"1344_CR47","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1109\/JBHI.2024.3476672","volume":"29","author":"J Ni","year":"2024","unstructured":"Ni, J. et al. MiRS-HF: a novel deep learning predictor for cancer classification and miRNA expression patterns. IEEE J. Biomed. Health Inform. 29, 679\u2013689 (2024).","journal-title":"IEEE J. Biomed. Health Inform."},{"key":"1344_CR48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41531-023-00461-9","volume":"9","author":"S Kaiser","year":"2023","unstructured":"Kaiser, S. et al. A proteogenomic view of Parkinson\u2019s disease causality and heterogeneity. npj Parkinson\u2019s. Dis. 9, 24 (2023).","journal-title":"npj Parkinson\u2019s. Dis."},{"key":"1344_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2024.1306546","volume":"15","author":"N Wakasugi","year":"2024","unstructured":"Wakasugi, N. et al. Harmonizing multisite data with the ComBat method for enhanced Parkinson\u2019s disease diagnosis via DAT-SPECT. Front. Neurol. 15, 1306546 (2024).","journal-title":"Front. Neurol."},{"key":"1344_CR50","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/jpm14040418","volume":"14","author":"W Evans","year":"2024","unstructured":"Evans, W., Meslin, E. M., Kai, J. & Qureshi, N. Precision medicine\u2014are we there yet? A narrative review of precision medicine\u2019s applicability in primary care. J. Personal. Med. 14, 418 (2024). Number: 4 Publisher: Multidisciplinary Digital Publishing Institute.","journal-title":"J. Personal. Med."},{"key":"1344_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.1064057","volume":"14","author":"M Frasier","year":"2022","unstructured":"Frasier, M., Fiske, B. K. & Sherer, T. B. Precision medicine for Parkinson\u2019s disease: the subtyping challenge. Front. Aging Neurosci. 14, 1064057 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"1344_CR52","volume":"31","author":"KY Yamashita","year":"2023","unstructured":"Yamashita, K. Y. others. Biomarkers in Parkinson\u2019s disease: a state of the art review. eNeurologicalSci 31, 100443 (2023).","journal-title":"eNeurologicalSci"},{"key":"1344_CR53","doi-asserted-by":"crossref","unstructured":"Iwaki, H. et al. Accelerating medicines partnership: Parkinson\u2019s disease. genetic resource. Mov. Disord. 36, 1795\u20131804. eprint: https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.28549 (2021).","DOI":"10.1002\/mds.28549"},{"key":"1344_CR54","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"K Marek","year":"2011","unstructured":"Marek, K. et al. The Parkinson progression marker initiative (PPMI). Prog. Neurobiol. 95, 629\u2013635 (2011).","journal-title":"Prog. Neurobiol."},{"key":"1344_CR55","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/mds.26438","volume":"31","author":"LS Rosenthal","year":"2016","unstructured":"Rosenthal, L. S. et al. The NINDS Parkinson\u2019s disease biomarkers program. Mov. Disord. 31, 915\u2013923 (2016).","journal-title":"Mov. Disord."},{"key":"1344_CR56","unstructured":"Cauwet, M. L. et al. Fully parallel hyperparameter search: Reshaped space-filling. In International Conference on Machine Learning. (PMLR, 2020)."},{"key":"1344_CR57","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong, E. R., DeLong, D. M. & Clarke-Pearson, D. L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44, 837\u2013845 (1988).","journal-title":"Biometrics"},{"key":"1344_CR58","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"SM Lundberg","year":"2020","unstructured":"Lundberg, S. M. et al. From local explanations to global understanding with explainable AI for trees. Nat. Mach. Intell. 2, 56\u201367 (2020).","journal-title":"Nat. Mach. Intell."},{"key":"1344_CR59","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz, C. G. et al. Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord.: 23, 2129\u20132170 (2008).","journal-title":"Mov. Disord.:"},{"key":"1344_CR60","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.parkreldis.2021.02.026","volume":"85","author":"KP Nguyen","year":"2021","unstructured":"Nguyen, K. P. et al. Predicting Parkinson\u2019s disease trajectory using clinical AND neuroimaging baseline measures. Parkinsonism Relat. Disord. 85, 44\u201351 (2021).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1344_CR61","doi-asserted-by":"crossref","unstructured":"Chaudhry, F., Kim, T. W., Elemento, O. & Betel, D. Machine learning analysis of population-wide plasma proteins identifies hormonal biomarkers of Parkinson\u2019s disease. Front Aging Neurosci. 18, 1730550 (2026).","DOI":"10.3389\/fnagi.2026.1730550"},{"key":"1344_CR62","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3233\/JPD-212860","volume":"12","author":"M Bartl","year":"2022","unstructured":"Bartl, M. et al. Longitudinal change and progression indicators using the movement disorder society-unified Parkinson\u2019s disease rating scale in two independent cohorts with early Parkinson\u2019s disease. J. Parkinson\u2019s. Dis. 12, 437\u2013452 (2022).","journal-title":"J. Parkinson\u2019s. Dis."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01344-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01344-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01344-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T07:08:56Z","timestamp":1782889736000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-026-01344-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1344"],"URL":"https:\/\/doi.org\/10.1038\/s41531-026-01344-5","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"7 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}